These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 28704126

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Impact of Adalimumab on Work Productivity and Activity Impairment in Japanese Patients with Rheumatoid Arthritis: Large-Scale, Prospective, Single-Cohort ANOUVEAU Study.
    Takeuchi T, Nakajima R, Komatsu S, Yamazaki K, Nakamura T, Agata N, Igarashi A, Tango T, Tanaka Y.
    Adv Ther; 2017 Mar; 34(3):686-702. PubMed ID: 28144917
    [Abstract] [Full Text] [Related]

  • 3. Effect of adalimumab on the work-related outcomes scores in patients with early rheumatoid arthritis receiving methotrexate.
    Emery P, Smolen JS, Ganguli A, Meerwein S, Bao Y, Kupper H, Chen N, Kavanaugh A.
    Rheumatology (Oxford); 2016 Aug; 55(8):1458-65. PubMed ID: 27114561
    [Abstract] [Full Text] [Related]

  • 4. Impact of etanercept on work and activity impairment in employed moderate to severe rheumatoid arthritis patients in the United States.
    Hone D, Cheng A, Watson C, Huang B, Bitman B, Huang XY, Gandra SR.
    Arthritis Care Res (Hoboken); 2013 Oct; 65(10):1564-72. PubMed ID: 23554320
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of work disability in Japanese patients with rheumatoid arthritis: from the TOMORROW study.
    Anno S, Sugioka Y, Inui K, Tada M, Okano T, Mamoto K, Koike T.
    Clin Rheumatol; 2018 Jul; 37(7):1763-1771. PubMed ID: 29525846
    [Abstract] [Full Text] [Related]

  • 6. Real-World Postmarketing Study of the Impact of Adalimumab Treatment on Work Productivity and Activity Impairment in Patients with Psoriatic Arthritis.
    Nakagawa H, Tanaka Y, Sano S, Kameda H, Taniguchi A, Kashiwagi T, Kawaberi T, Kimura J, Morita A.
    Adv Ther; 2019 Mar; 36(3):691-707. PubMed ID: 30661197
    [Abstract] [Full Text] [Related]

  • 7. Improvement in work place and household productivity for patients with early rheumatoid arthritis treated with adalimumab plus methotrexate: work outcomes and their correlations with clinical and radiographic measures from a randomized controlled trial companion study.
    van Vollenhoven RF, Cifaldi MA, Ray S, Chen N, Weisman MH.
    Arthritis Care Res (Hoboken); 2010 Feb; 62(2):226-34. PubMed ID: 20191522
    [Abstract] [Full Text] [Related]

  • 8. Sustained improvement in work outcomes in employed patients with rheumatoid arthritis during 2 years of adalimumab therapy: an observational cohort study.
    Behrens F, Tony HP, Koehm M, Schwaneck EC, Gnann H, Greger G, Burkhardt H, Schmalzing M.
    Clin Rheumatol; 2020 Sep; 39(9):2583-2592. PubMed ID: 32206973
    [Abstract] [Full Text] [Related]

  • 9. Productivity loss of Japanese patients with rheumatoid arthritis - A cross-sectional survey.
    Sruamsiri R, Mahlich J, Tanaka E, Yamanaka H.
    Mod Rheumatol; 2018 May; 28(3):482-489. PubMed ID: 28849715
    [Abstract] [Full Text] [Related]

  • 10. Short-term influence of adalimumab on work productivity outcomes in patients with rheumatoid arthritis.
    Zhang W, Bansback N, Guh D, Li X, Nosyk B, Marra CA, Anis AH.
    J Rheumatol; 2008 Sep; 35(9):1729-36. PubMed ID: 18688916
    [Abstract] [Full Text] [Related]

  • 11. Quantifying the economic burden of productivity loss in rheumatoid arthritis.
    Filipovic I, Walker D, Forster F, Curry AS.
    Rheumatology (Oxford); 2011 Jun; 50(6):1083-90. PubMed ID: 21245074
    [Abstract] [Full Text] [Related]

  • 12. Employer model of workplace impacts of anti-TNF therapy for rheumatoid arthritis.
    Birnbaum H, Pike C, Kaufman R, Cifaldi M.
    J Occup Environ Med; 2009 Oct; 51(10):1167-76. PubMed ID: 19786900
    [Abstract] [Full Text] [Related]

  • 13. Productivity cost model of the treatment of rheumatoid arthritis with abatacept.
    Burton WN, Morrison A, Yuan Y, Li T, Marioni RE, Maclean R.
    J Med Econ; 2008 Oct; 11(1):3-21. PubMed ID: 19450107
    [Abstract] [Full Text] [Related]

  • 14. Patient-reported outcomes from a phase 3 study of baricitinib versus placebo or adalimumab in rheumatoid arthritis: secondary analyses from the RA-BEAM study.
    Keystone EC, Taylor PC, Tanaka Y, Gaich C, DeLozier AM, Dudek A, Zamora JV, Cobos JAC, Rooney T, Bono S, Arora V, Linetzky B, Weinblatt ME.
    Ann Rheum Dis; 2017 Nov; 76(11):1853-1861. PubMed ID: 28798049
    [Abstract] [Full Text] [Related]

  • 15. Factors associated with absenteeism, presenteeism and activity impairment in patients in the first years of RA.
    Bansback N, Zhang W, Walsh D, Kiely P, Williams R, Guh D, Anis A, Young A.
    Rheumatology (Oxford); 2012 Feb; 51(2):375-84. PubMed ID: 22179728
    [Abstract] [Full Text] [Related]

  • 16. The impact of rheumatoid arthritis on the burden of disease in urban China.
    Langley PC, Mu R, Wu M, Dong P, Tang B.
    J Med Econ; 2011 Feb; 14(6):709-19. PubMed ID: 21899486
    [Abstract] [Full Text] [Related]

  • 17. Critical analysis of economic tools and economic measurement applied to rheumatoid arthritis.
    Her M, Kavanaugh A.
    Clin Exp Rheumatol; 2012 Feb; 30(4 Suppl 73):S107-11. PubMed ID: 23078839
    [Abstract] [Full Text] [Related]

  • 18. Pharmacoeconomic analysis of biological disease modifying antirheumatic drugs in patients with rheumatoid arthritis based on real-world data from the IORRA observational cohort study in Japan.
    Tanaka E, Inoue E, Yamaguchi R, Shimizu Y, Kobayashi A, Sugimoto N, Hoshi D, Shidara K, Sato E, Seto Y, Nakajima A, Momohara S, Taniguchi A, Yamanaka H.
    Mod Rheumatol; 2017 Mar; 27(2):227-236. PubMed ID: 27472516
    [Abstract] [Full Text] [Related]

  • 19. Validity of the work productivity and activity impairment questionnaire--general health version in patients with rheumatoid arthritis.
    Zhang W, Bansback N, Boonen A, Young A, Singh A, Anis AH.
    Arthritis Res Ther; 2010 Mar; 12(5):R177. PubMed ID: 20860837
    [Abstract] [Full Text] [Related]

  • 20. Improvement in work productivity among psoriatic arthritis patients treated with biologic or targeted synthetic drugs: a systematic literature review and meta-analysis.
    Gossec L, Humphries B, Rutherford M, Taieb V, Willems D, Tillett W.
    Arthritis Res Ther; 2024 Feb 15; 26(1):50. PubMed ID: 38360699
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.